European Medicines Agency - Regulatory - Regulation of medicines

5 -Training and educational capacity to build competencies



    Description

Name

 

ECAPN - European Child & Adolescent Psychopharmacology Network

Evidence of collaboration with regulatory authorities Yes Members of the network are regularly consulted by EMA and National Authorities for paediatric CNS medications; They apply to EMA for Paediatric Investigation Plans (PIPs) for specific Academic Studies/ projects. EMA is also involved in a recent project aimed at an update of unmet needs in paediatric psychopharmacology.
Capacity to provide competent consultation to regulatory authorities Yes Members of the network are regularly consulted by EMA and National Authorities for paediatric CNS medications; They apply to EMA for Paediatric Investigation Plans (PIPs) for specific Academic Studies/ projects. EMA is also involved in a recent project aimed at an update of unmet needs in paediatric psychopharmacology.
Formal meetings for clinical trials Yes 6 to 8 a year
Training courses given over the last 2 years Yes ECNP School on Child & Adolescent Neuropsychopharmacology: https://www.ecnp.eu/about-ecnp/history/past-ecnp-meetings/past-schools.aspx) - National Training Programs - Training Programs , including GCP, for specific projects including GCP for specific sponsored clinical trials.
Training courses received over the last 2 years Yes ECNP School on Child & Adolescent Neuropsychopharmacology: https://www.ecnp.eu/about-ecnp/history/past-ecnp-meetings/past-schools.aspx) - National Training Programs - Training Programs , including GCP, for specific projects including GCP for specific sponsored clinical trials.
Promotion of participation in clinical trials in countries with limited resources Yes Countries with limited resources have been involved in academic studies and suggested to Company CROs
List of Countries